154
Participants
Start Date
March 29, 2022
Primary Completion Date
April 30, 2026
Study Completion Date
July 31, 2029
Tulisokibart
Tulisokibart administered at timepoints as directed by the protocol
Companion diagnostic ( CDx)
CDx+ or CDx-
Placebo
Placebo
Budai Irgalmasrendi Korhaz ( Site 4252), Budapest
Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet ( Site 4253), Budapest
Hopitaux Universitaires de Geneve HUG ( Site 4503), Geneva
Clínica Privada Independencia ( Site 4802), Munro
Institute of Rheumatology LLC ( Site 4752), Kyiv
UZ Leuven ( Site 4402), Leuven
Inselspital Bern ( Site 4502), Bern
St Vincents Hospital Melbourne ( Site 4051), Melbourne
CHU de Liege ( Site 4400), Liège
Debreceni Egyetem Klinikai Kozpont ( Site 4251), Debrecen
Royal Adelaide Hospital ( Site 4050), Adelaide
Centro de Investigación Instituto Médico Río Cuarto ( Site 4801), Río Cuarto
Pecsi Tudomanyegyetem AOK ( Site 4250), Pécs
Universitaetsspital Zuerich ( Site 4500), Zurich
UZ Gent ( Site 4401), Ghent
Kantonsspital St. Gallen ( Site 4501), Sankt Gallen
Hospital For Special Surgery ( Site 4020), New York
A.O.U. Citta della Salute e della Scienza di Torino ( Site 4304), Turin
Instituto de Ginecologia y Reproduccion ( Site 4952), Lima
University of Pittsburgh Medical Center ( Site 4016), Pittsburgh
Ospedale Policlinico San Martino ( Site 4305), Genova
Rheumazentrum am Krankenhaus Bad Doberan ( Site 4150), Hohenfelde B Bad Doberan
MedStar Georgetown University Hospital ( Site 4005), Washington D.C.
IRCCS Osp. Maggiore Policlinico ( Site 4306), Milan
Ospedale San Raffaele di Milano ( Site 4307), Milan
Vinnytsia Nat Med University n.a.M.Pyrogov,City Clinical Hospital #1 ( Site 4751), Vinnytsia
Johns Hopkins Asthma and Allergy Center [Baltimore, MD] ( Site 4018), Baltimore
Fondazione IRCCS Policlinico San Matteo ( Site 4303), Pavia
Hospital Universitario Ramon y Cajal ( Site 4101), Madrid
Hospital Universitario 12 de Octubre ( Site 4106), Madrid
Hospital Regional Universitario de Malaga ( Site 4104), Málaga
Medical University of South Carolina - PPDS ( Site 4004), Charleston
Centro de Investigación y Tratamiento Reumatológico S.C ( Site 4902), Mexico City
Hospital Central de Asturias ( Site 4109), Oviedo
CHU de Bordeaux. Hopital Pellegrin ( Site 4202), Bordeaux
Arcispedale Santa Maria Nuova ( Site 4300), Reggio Emilia
University of Toledo Medical Center ( Site 4002), Toledo
Cleveland Clinic Foundation ( Site 4019), Cleveland
PanAmerican Clinical Research - Guadalajara ( Site 4900), Guadalajara
"ME Ternopil Regional Clinical Hospital of Ternopil Regional Council ( Site 4750)", Ternopil
Hospital Universitario Doctor Peset ( Site 4103), Valencia
University of Michigan Hospital ( Site 4001), Ann Arbor
Rabin Medical Center ( Site 4603), Petach Tikvah
Hospital Clinico Universitario Lozano Blesa ( Site 4100), Zaragoza
Azienda Ospedaliera Universitaria Careggi ( Site 4301), Florence
Universitaetsklinikum Koeln ( Site 4151), Cologne
Froedtert and Medical College of Wisconsin ( Site 4012), Milwaukee
Hôpital Claude Huriez ( Site 4200), Lille
Kerckhoff-Klinik-Forschungs-GmbH ( Site 4153), Bad Nauheim
Hopital Cochin ( Site 4203), Paris
UT Physicians Rheumatology ( Site 4007), Houston
Universitaetsklinikum Freiburg ( Site 4152), Freiburg im Breisgau
National Jewish Health Medical Center ( Site 4015), Denver
Mayo Clinic - Scottsdale ( Site 4014), Phoenix
Pacific Arthritis Care Center ( Site 4008), Los Angeles
Cedars Sinai Medical Center ( Site 4010), Los Angeles
Stanford Health Care ( Site 4009), Palo Alto
Galilee Medical Center ( Site 4602), Nahariya
ONCOCENTRO APYS ( Site 4852), Viña del Mar
Rambam Medical Center ( Site 4601), Haifa
Meir Medical Center. ( Site 4604), Kfar Saba
Centro de especialidades médicas Vanguardia ( Site 4850), Temuco
Sheba Medical Center ( Site 4605), Ramat Gan
Tel Aviv Sourasky Medical Center ( Site 4606), Tel Aviv
Clinica Dermacross ( Site 4853), Vitacura
BIOCINETIC Ltda ( Site 4854), Santiago
Centro de Investigacion Clinica UC CICUC ( Site 4855), Santiago
Centro Internacional de Estudios Clinicos CIEC ( Site 4851), Santiago
UCLA School of Medicine ( Site 4006), Los Angeles
Yale University ( Site 4017), New Haven
Massachusetts General Hospital ( Site 4003), Boston
Boston University School of Medicine ( Site 4021), Boston
Rutgers Robert Wood Johnson Medical School ( Site 4013), New Brunswick
Consultorios Médicos Dr. Doreski ( Site 4800), CABA
Instituto Medico de la Fundacion Estudios Clinicos ( Site 4803), Rosario
University Of Alberta Hospital ( Site 4702), Edmonton
St. Joseph's Health Care London ( Site 4701), London
Mount Sinai Hospital [Toronto, Canada] ( Site 4700), Toronto
Azienda Policlinico Umberto I ( Site 4302), Roma
Radboud University Medical Center ( Site 4650), Nijmegen
Oslo Universitetssykehus HF. Rikshospitalet ( Site 4350), Oslo
Twoja Przychodnia Poznanskie Centrum Medyczne ( Site 4452), Poznan
Narodowy Instytut Geriatrii Reumatologii i Rehabilitacji im.Prof. El. Reicher-ul.Spartanska 1 ( Site, Warszawa
Szpital Uniwersytecki nr 2 im. dr Jana Biziela w Bydgoszczy ( Site 4454), Bydgoszcz
Centrum Medyczne Oporow ( Site 4455), Wroclaw
Centrum Medyczne Reuma Park NZOZ ( Site 4450), Warsaw
Uniwersytecki Szpital Kliniczny w Bialymstoku - Marii Sklodowskiej-Curie 24A ( Site 4451), Bialystok
Szpital Specjalistyczny nr 1 w Bytomiu ( Site 4453), Bytom
HOSPITAL CLÍNIC DE BARCELONA ( Site 4105), Barcelona
Hospital Universitario Vall d'Hebron - PPDS ( Site 4107), Barcelona
Hospital Santa Creu i Sant Pau ( Site 4102), Barcelona
Kyiv City Clinical Hospital # 3 ( Site 4754), Kyiv
Medical Center OK!Clinic+LLC International Institute of Clinical Research ( Site 4753), Kyiv
Royal Free Hospital ( Site 4550), London
Chapel Allerton Hospital ( Site 4551), Leeds
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
INDUSTRY